Fortress Biotech
(NASDAQ) FBIOP
Fortress Biotech Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$66.16M
Net Income (TTM)
$127.77M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
0.29 (Low)
Dividend
$0.00
Beta (Volatility)
0.29 (Low)
Price
$16.70
Volume
14,241
Open
$16.43
Price
$16.70
Volume
14,241
Open
$16.43
Previous Close
$16.70
Daily Range
$16.06 - $16.70
52-Week Range
$6.27 - $16.70
Dividend
$0.00
Beta (Volatility)
0.29 (Low)
Price
$16.70
Volume
14,241
Open
$16.43
Previous Close
$16.70
Daily Range
$16.06 - $16.70
52-Week Range
$6.27 - $16.70
FBIOP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Fortress Biotech
FBIOP Financials
Key Financial Metrics (TTM)
Gross Margin
65%
Operating Margin
-84%
Net Income Margin
2%
Return on Equity
0%
Return on Capital
-22%
Return on Assets
36%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.39%
Stock Overview
Market Cap
$0.00
Shares Outstanding
0
Volume
14.24K
Avg. Volume
19.76K
Financials (TTM)
Gross Profit
$42.34M
Operating Income
$70.22M
EBITDA
$20.16M
Operating Cash Flow
$65.78M
Capital Expenditure
$0.00
Free Cash Flow
$65.78M
Cash & ST Invst.
$79.38M
Total Debt
$74.30M
Fortress Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$16.04M
+22.1%
Gross Profit
$8.69M
+4.1%
Gross Margin
54.21%
N/A
Market Cap
$0.00
N/A
Market Cap/Employee
N/A
N/A
Employees
101
N/A
Net Income
$110.37M
+1142.8%
EBITDA
$6.04M
+71.2%
Quarterly Fundamentals
Net Cash
$202.21M
+1082.3%
Accounts Receivable
$25.51M
+39.1%
Inventory
$9.29M
-25.6%
Long Term Debt
$48.91M
-30.3%
Short Term Debt
$4.72M
+17.0%
Return on Assets
35.80%
N/A
Return on Invested Capital
-22.02%
N/A
Free Cash Flow
$203.85M
+1142.0%
Operating Cash Flow
$203.85M
+1142.0%